跳转到主内容

非常抱歉,我们不完全支持您的浏览器。如果您可以选择,请升级到较新版本或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更高版本。如果您无法进行此操作且需要支持,请将您的反馈发送给我们。

全新设计的官网为您带来全新体验,期待您的反馈在新的选项卡/窗口中打开

Elsevier
通过我们出版
Video

Clinicalkey AI in action: What is the management of hypercalciuria in a person with a second renal stone?

| 2 分钟阅读

ClinicalKey AI combines trusted, evidence-based clinical content with conversational search powered by generative AI to support clinicians in delivering high-quality patient care.  Clinicians gain a powerful ally with ClinicalKey AI by providing quick access to trusted clinical knowledge and allowing them to focus on what truly matters, quality patient care. Interested healthcare organizations can contact us today to learn more.  

Hypercalciuria poster image

Hypercalciuria

The management of hypercalciuria in a person with a second renal stone involves dietary modifications, increased fluid intake, and potentially medication such as thiazide diuretics or potassium citrate.[1-4]

• Dietary modifications include reducing sodium intake to no more than 2g per day and limiting animal protein intake to 0.8 to 1.0g/kg per day. Adequate calcium intake (1000mg per day for a 19- to 50-year-old man or woman) is also recommended, preferably from dairy products rather than supplements.[1]

• Increasing fluid intake to achieve a urine volume of more than 2.5 L daily can help reduce the risk of stone recurrence.[2][4]

• Thiazide diuretics, such as chlorthalidone (12.5 to 25mg/day), can be beneficial for patients with persistent hypercalciuria. These medications lower urinary calcium and reduce recurrent stone formation by about 50%. However, they are effective only if patients restrict dietary sodium.[1]

• Potassium citrate therapy can also be beneficial, especially for patients with recurrent calcium stones and low urinary citrate levels. It increases urinary citrate excretion, binds urinary calcium, and further decreases recurrent stone formation.[1-2]

• In some cases, allopurinol may be prescribed for patients with recurrent calcium oxalate stones who have hyperuricosuria and urinary calcium levels within the reference range.[2]

Additional Information

References

1.Nephrolithiasis.在新的选项卡/窗口中打开 Bushinsky, David A., In Goldman-Cecil Medicine (pp. 803).

2.Nephrolithiasis.在新的选项卡/窗口中打开,Elsevier ClinicalKey, Clinical Overview

3.Urinary Lithiasis.在新的选项卡/窗口中打开,Di Carlo, Heather N., Crigger, Chad B., In Nelson Textbook of Pediatrics (pp. 3311).

4.Urinary Stone Disease: Diagnosis, Medical Therapy, and Surgical Management.在新的选项卡/窗口中打开,Ludwig WW, Matlaga BR., The Medical Clinics of North America. 2018;102(2):265-277. doi:10.1016/j.mcna.2017.10.004.

Answer generated on May 13, 2024 

Note: User acknowledges that these materials are provided for use at no charge as part of Elsevier’s efforts to support healthcare providers and patients. The information contained within the website is intended as a supplement to, and not a substitute for, the knowledge, expertise, skill and judgment of healthcare professionals involved in patient care. The content within this page may not be re-used, modified or re-distributed without prior written permission.